ArticleJournal of experimental & clinical cancer research : CR2026
Methyl-cantharidimide suppresses cyclin-dependent kinase 1 (CDK1) and induces oxeiptosis in liver cancer.
Yi-Dong Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.